For U.S. Cardiologists. Age and Income Continue to Rise
Feature | Cardiovascular Business

Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm MedAxiom finds that overall, cardiology compensation continues to increase. The company’s fifth annual Cardiovascular Provider Compensation and Production Survey also revealed that one in five cardiologists is over the age of 61, and that overall compensation for private cardiologists is increasing faster than that of their integrated counterparts; the differential in compensation is at its lowest point in five years.

Home October 03, 2017
Home
News | Cardiovascular Information Systems (CVIS)

October 3, 2017 – Medical Metrics, an experienced core laboratory for multi-center clinical trials, has implemented the ...

Home October 03, 2017
Home
News | Cardiovascular Business

October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its ...

Home October 02, 2017
Home
News | Catheters

October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S. Food and ...

Home October 02, 2017
Home
News | Heart Valve Technology

Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in everyday clinical practice. Studying patients with severe symptomatic aortic stenosis at an intermediate, high or extreme risk for open-heart surgery, the FORWARD PRO Clinical Study will evaluate longer-term performance (out to five years) of the next-generation self-expanding transcatheter aortic valve implantation (TAVI) system, which was recently approved for commercial use in Europe and United States.

Home October 02, 2017
Home
News

October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held ...

Home October 02, 2017
Home
Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.
Feature

October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...

Home October 02, 2017
Home
Technology | Cath Lab

September 29, 2017 — TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the premarket ...

Home September 29, 2017
Home
Technology | Atherectomy Devices

Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the Pantheris Lumivascular atherectomy system.

Home September 29, 2017
Home
News | Stroke

September 28, 2017 — New research revealed that on average, more than 75 percent of people aged 65 and older worldwide ...

Home September 28, 2017
Home
Videos | Chronic Total Occlusion (CTO)

Farouc Jaffer, M.D., Ph.D., director of coronary interventions at Massachusetts General Hospital, discusses the newest ...

Home September 28, 2017
Home
News | Patient Engagement

September 28, 2017 — The AstraZeneca HealthCare Foundation’s Connections for Cardiovascular Health (CCH) program is ...

Home September 28, 2017
Home
Technology | Ventricular Assist Devices (VAD)

Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP heart pump. Culminating from five years of research, this approval follows the prior FDA Humanitarian Device Exemption (HDE) received in January 2015 and adds the Impella RP heart pump to Abiomed's platform of PMA-approved devices.

Home September 28, 2017
Home
Technology | Implantable Cardioverter Defibrillator (ICD)

September 27, 2017 — Boston Scientific recently launched the Resonate family of implantable cardioverter defibrillator ...

Home September 27, 2017
Home
News | Interventional Radiology

Toshiba Medical announced it will highlight several of its latest vascular and interventional imaging solutions at the 2017 Annual Meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.

Home September 27, 2017
Home
Subscribe Now